Amino Acid Supplementation in Recovery From Traumatic Brain Injury



Status:Recruiting
Conditions:Hospital, Neurology
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - 65
Updated:2/8/2015
Start Date:November 2011
Contact:Kate M Randolph, B.S.
Email:kmrandol@utmb.edu
Phone:409-772-8126

Use our guide to learn which trials are right for you!

Traumatic brain injury (TBI) is a leading cause of death and disability in young people. It
has been called the "signature wound" of the Iraq war because of its frequency among troops.
TBI is associated with many chronic disabilities. Physical alterations include reduced
exercise tolerance and profound muscle weakness, whereas psychological alterations include
diminished sense of well-being, depression, fatigue and anxiety. Muscle and brain tissues
rely upon circulating blood amino acids as precursors for metabolic functions. The
investigators have shown that even one year after injury, plasma valine, an essential amino
acid (EAA), was markedly reduced in patients with TBI compared to healthy controls. The
investigators speculate that low plasma valine concentration contributes to chronic fatigue
after TBI, since valine and tryptophan compete for the same transporter into the brain, and
a low plasma valine concentration will allow more tryptophan to be transported. As a
consequence, increased brain tryptophan will increase serotonin production, which may
significantly contribute to the development of fatigue. Thus, the investigators will test if
restoring valine concentration in persons with TBI may reduce fatigue perception and improve
physical and neuropsychological function. Further, the investigators have previously shown
that EAA intake has an anabolic effect in healthy young and elderly individuals. However, no
data are currently available in persons recovering from TBI. Thus,the investigators will
also test if EAA and/or valine can improve muscle mass in patients with TBI.


Inclusion Criteria:

1. Presence of traumatic brain injury

2. Age 18-65 years

3. Ability to sign informed consent

4. >3 months post-injury, <36 months post-injury

5. Ambulatory or require minimal to moderate assistance for safe ambulation

Exclusion Criteria:

1. Subjects with cardiac abnormalities considered exclusionary by the study physicians

2. Subjects with uncontrolled metabolic disease, including liver or renal disease

3. Subjects with cancer or recently (6 months) treated cancer other than basal cell
carcinoma

4. Any subject currently on a weight-loss diet or a body mass index >34 kg/m2

5. Recent anabolic or corticosteroids use (within 3 months)

6. Dementia

7. Inability to tolerate an upright position

8. Postural reflexes prohibiting ambulation and inability to follow 2-step commands

9. Any other condition or event considered exclusionary by the PIs and covering
physician
We found this trial at
2
sites
301 University Blvd
Galveston, Texas 77555
(409) 772-1011
University of Texas Medical Branch Established in 1891 as the University of Texas Medical Department,...
?
mi
from
Galveston, TX
Click here to add this to my saved trials
Galveston, Texas 77550
?
mi
from
Galveston, TX
Click here to add this to my saved trials